Call Kauvery Hospitals
Appointments

Electronic City:

Kauvery Electronic City Phone 080 6801 6801

Marathahalli:

Kauvery Marathahalli Phone 080 4180 4180

Emergency

Kauvery Hospitals Ambulance 080 6801 6901

Find a Doctor Book Online Appointment

Home > Doctors > Dr. Harish V Reddy

Dr. Harish V Reddy

Senior Consultant – Medical Oncology

Qualification

MBBS, MRCP (UK), MSc (Oncology), FRCR (UK), ESMO Certified, MBA (Healthcare)

Languages Known

English, Hindi, Kannada

Location

Kauvery Hospital - Marathahalli

Profile Brief

Dr. Harish V Reddy is a globally trained Clinical Oncologist with over 20 years of experience in cancer care, including 9 years as a Consultant in the NHS, UK. He specializes in the management of solid tumors through chemotherapy, immunotherapy, and precision oncology. A Fellow of the Royal College of Radiologists and ESMO-certified medical oncologist, Dr. Reddy is known for integrating international protocols with patient-centered care.

He holds an MSc in Oncology from the University of Nottingham and an MBA in Healthcare Leadership. His clinical expertise spans across breast, lung, gastrointestinal, prostate, and head & neck cancers. He has played a lead role in implementing real-world evidence programs, digital oncology tools, and translational research initiatives.

At Kauvery Hospital, Marathahalli, Dr. Reddy brings a vision of outcome-based, compassionate cancer care that is globally benchmarked and locally accessible.

Past Experience

  • Group Medical Director – HCG Chain of Hospitals - 2023 - 2025
  • Consultant - Nottingham University hospitals NHS trust (Sep 2019 –May2021) & Dec `21 till May `23
  • Consultant - Mid Yorks Hospitals NHS trust (Mar 2021 till May 2023)
  • Consultant - Northampton General Hospital (May 2021 till Dec 2021)
  • Consultant - Peterborough City hospital (Jul 2017 – Sep 2019)
  • Consultant - Southampton General hospital (Sep 2014 – Jun 2017)

Area of Expertise

  • Medical management of solid tumors and haematological malignancies.
  • Chemotherapy, immunotherapy, and targeted therapies
  • Personalized cancer care using molecular and genetic profiling
  • Tumor board-based multidisciplinary treatment planning
  • Survivorship care and long-term follow-up Care

Research & Publication

  1. Frequent early failure of Kivexa containing regimes associated with new emergence of K65R. Reddy HV, Hale A, Lacey CJ.Journal of HIV therapy Vol 11.4, Abs.5 Dec 2006
  2. Is it worth giving adjuvant chemotherapy to patients with Oesophagogastric cancer who do not show a histopathological response to neoadjuvant chemotherapy? Chris Bowman, John Saunders, Harish Reddy, Vince Pang, Errum Mumtaz, Irshad Soomro, Srinivasan Madhusudan, Simon Parsons Br J Surg 2014;101(Suppl. 6): 1
  3. A Arora, SJ Storr, H Reddy, DN Lobo, S Madhusudan, AM Zaitoun, O085 CD10 expression in carcinomas of the pancreas, bile duct and ampulla, British Journal of Surgery, Volume 109, Issue Supplement_4, August 2022, znac242.085, https://doi.org/10.1093/bjs/znac242.085

Affiliation and Membership

  • Royal College of Radiologists – Fellow
  • Karnataka Medical Council
  • Consortium of Accredited Healthcare Organizations (CAHO), India
Book An Appointment Content

Our Locations